Skip to main content
Top
Published in: Inflammation 2/2022

01-04-2022 | Ankylosing Spondylitis | Original Article

Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients

Authors: Alireza Rezaiemanesh, Mahdi Mahmoudi, Ali Akbar Amirzargar, Mahdi Vojdanian, Farhad Babaie, Jila Mahdavi, Misagh Rajabinejad, Ahmad Reza Jamshidi, Mohammad Hossein Nicknam

Published in: Inflammation | Issue 2/2022

Login to get access

Abstract

The inflammatory interleukin (IL)-23/IL-17 axis plays an important role in the pathogenesis of ankylosing spondylitis (AS), but with an unknown regulatory mechanism. This study aimed to investigate the role of endoplasmic reticulum (ER) stress and autophagy pathway in the expression of IL-23 in peripheral blood–derived macrophages in AS patients. Peripheral blood samples were obtained from 15 AS and 15 healthy control subjects. MACS was used to isolate monocytes from PBMCs. Then, M-CSF was used to differentiate monocytes to M2 macrophages. IFN-γ and/or LPS were used to activate macrophages and M2 polarization towards M1 macrophages. Thapsigargin was used to induce ER stress and 3-MA to inhibit autophagy. The purity of extracted monocytes and macrophage markers was evaluated by flow cytometry. mRNA expression of HLA-B and-B27, ER stress–related genes, autophagy-related genes, and IL-23p19 was performed using RT-qPCR. Soluble levels of IL-23p19 were measured using ELISA. Significant increase in mRNA expression of HLA-B, HLA-B27, BiP, XBP1, CHOP, and PERK mRNAs was observed in macrophages of AS patients before and after stimulation with IFN-γ and LPS. No significant change in autophagy gene expression was detected. mRNA and soluble levels of IL-23p19 demonstrated a significant increase in macrophages of AS patients compared to healthy subjects. ER stress induction led to a significant increase in IL-23p19 in macrophages. Inhibition of autophagy did not affect IL-23 expression. ER stress, unlike autophagy, is associated with increased IL-23 levels in macrophages of AS patients.
Key Messages
  • ER stress in macrophages from AS patients plays a role in the increased production of IL-23.
  • The autophagy pathway is not involved in the modulation of IL-23 production by AS macrophages.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ranganathan, V., E. Gracey, M.A. Brown, R.D. Inman, and N. Haroon. 2017. Pathogenesis of ankylosing spondylitis—recent advances and future directions. Nature Reviews Rheumatology 13: 359.CrossRef Ranganathan, V., E. Gracey, M.A. Brown, R.D. Inman, and N. Haroon. 2017. Pathogenesis of ankylosing spondylitis—recent advances and future directions. Nature Reviews Rheumatology 13: 359.CrossRef
2.
go back to reference Mahmoudi, M., S. Aslani, M.H. Nicknam, J. Karami, and A.R. Jamshidi. 2017. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Modern rheumatology 27: 198–209.CrossRef Mahmoudi, M., S. Aslani, M.H. Nicknam, J. Karami, and A.R. Jamshidi. 2017. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Modern rheumatology 27: 198–209.CrossRef
3.
go back to reference Mohammadi H, F., Babaie, M., Hemmatzadeh, G., Azizi, M., Hajaliloo, A. A., Ebrahimi, T., Kazemi, M., Yousefi, A., Rezaiemanesh, E., afarzadeh, E., Baghbani. 2018 Oct 20. Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients. Iranian Journal of Allergy, Asthma and Immunology 464–474. Mohammadi H, F., Babaie, M., Hemmatzadeh, G., Azizi, M., Hajaliloo, A. A., Ebrahimi, T., Kazemi, M., Yousefi, A., Rezaiemanesh, E., afarzadeh, E., Baghbani. 2018 Oct 20. Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients. Iranian Journal of Allergy, Asthma and Immunology 464–474.
4.
go back to reference García-Medel, N., A. Sanz-Bravo, C. Alvarez-Navarro, P. Gómez-Molina, E. Barnea, M. Marcilla, A. Admon, and J.A.L. de Castro. 2014. Peptide handling by HLA-B27 subtypes influences their biological behavior association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Molecular & Cellular Proteomics 13: 3367–3380.CrossRef García-Medel, N., A. Sanz-Bravo, C. Alvarez-Navarro, P. Gómez-Molina, E. Barnea, M. Marcilla, A. Admon, and J.A.L. de Castro. 2014. Peptide handling by HLA-B27 subtypes influences their biological behavior association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Molecular & Cellular Proteomics 13: 3367–3380.CrossRef
5.
go back to reference Dashti, N., M. Mahmoudi, S. Aslani, and A. Jamshidi. 2018. HLA-B* 27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 670: 15–21.CrossRef Dashti, N., M. Mahmoudi, S. Aslani, and A. Jamshidi. 2018. HLA-B* 27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 670: 15–21.CrossRef
6.
go back to reference Schittenhelm, R.B., T.C.L.K. Sian, P.G. Wilmann, N.L. Dudek, and A.W. Purcell. 2015. Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLA–B27 allotypes. Arthritis & rheumatology 67: 702–713.CrossRef Schittenhelm, R.B., T.C.L.K. Sian, P.G. Wilmann, N.L. Dudek, and A.W. Purcell. 2015. Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLA–B27 allotypes. Arthritis & rheumatology 67: 702–713.CrossRef
7.
go back to reference Rysnik, O., K. McHugh, L. van Duivenvoorde, M. van Tok, G. Guggino, J. Taurog, S. Kollnberger, F. Ciccia, D. Baeten, and P. Bowness. 2016. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Journal of autoimmunity 70: 12–21.CrossRef Rysnik, O., K. McHugh, L. van Duivenvoorde, M. van Tok, G. Guggino, J. Taurog, S. Kollnberger, F. Ciccia, D. Baeten, and P. Bowness. 2016. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Journal of autoimmunity 70: 12–21.CrossRef
8.
go back to reference Colbert, R.A., M.L. DeLay, E.I. Klenk, and G. Layh-Schmitt. 2010. From HLA-B27 to spondyloarthritis: A journey through the ER. Immunological reviews 233: 181–202.CrossRef Colbert, R.A., M.L. DeLay, E.I. Klenk, and G. Layh-Schmitt. 2010. From HLA-B27 to spondyloarthritis: A journey through the ER. Immunological reviews 233: 181–202.CrossRef
9.
go back to reference Bowness, P., A. Ridley, J. Shaw, A.T. Chan, I. Wong-Baeza, M. Fleming, F. Cummings, A. McMichael, and S. Kollnberger. 2011. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. The Journal of Immunology 186: 2672–2680.CrossRef Bowness, P., A. Ridley, J. Shaw, A.T. Chan, I. Wong-Baeza, M. Fleming, F. Cummings, A. McMichael, and S. Kollnberger. 2011. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. The Journal of Immunology 186: 2672–2680.CrossRef
10.
go back to reference Babaie, F., M. Hasankhani, H. Mohammadi, E. Safarzadeh, A. Rezaiemanesh, R. Salimi, B. Baradaran, and Z. Babaloo. 2018. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunology letters 196: 52–62.CrossRef Babaie, F., M. Hasankhani, H. Mohammadi, E. Safarzadeh, A. Rezaiemanesh, R. Salimi, B. Baradaran, and Z. Babaloo. 2018. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunology letters 196: 52–62.CrossRef
11.
go back to reference Rezaiemanesh, A., M. Abdolmaleki, K. Abdolmohammadi, H. Aghaei, F.D. Pakdel, Y. Fatahi, N. Soleimanifar, M. Zavvar, and M.H. Nicknam. 2018. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100: 198–204.CrossRef Rezaiemanesh, A., M. Abdolmaleki, K. Abdolmohammadi, H. Aghaei, F.D. Pakdel, Y. Fatahi, N. Soleimanifar, M. Zavvar, and M.H. Nicknam. 2018. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100: 198–204.CrossRef
12.
go back to reference Ridley, A., H. Hatano, I. Wong-Baeza, J. Shaw, K.K. Matthews, H. Al-Mossawi, K. Ladell, D.A. Price, P. Bowness, and S. Kollnberger. 2016. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA–B27 licenses pathogenic t cell differentiation in spondyloarthritis. Arthritis & rheumatology 68: 901–914.CrossRef Ridley, A., H. Hatano, I. Wong-Baeza, J. Shaw, K.K. Matthews, H. Al-Mossawi, K. Ladell, D.A. Price, P. Bowness, and S. Kollnberger. 2016. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA–B27 licenses pathogenic t cell differentiation in spondyloarthritis. Arthritis & rheumatology 68: 901–914.CrossRef
13.
go back to reference Ciccia, F., and N. Haroon. 2016. Autophagy in the pathogenesis of ankylosing spondylitis. Clinical rheumatology 35: 1433–1436.CrossRef Ciccia, F., and N. Haroon. 2016. Autophagy in the pathogenesis of ankylosing spondylitis. Clinical rheumatology 35: 1433–1436.CrossRef
14.
go back to reference Neerinckx, B., S. Carter, and R. . 2014. Lories. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Arthritis & Rheumatology 66: S844–S844. Neerinckx, B., S. Carter, and R. . 2014. Lories. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Arthritis & Rheumatology 66: S844–S844.
15.
go back to reference Rezaiemanesh, A., M. Mahmoudi, A.A. Amirzargar, M. Vojdanian, A.R. Jamshidi, and M.H. Nicknam. 2017. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Modern rheumatology 27: 862–867.CrossRef Rezaiemanesh, A., M. Mahmoudi, A.A. Amirzargar, M. Vojdanian, A.R. Jamshidi, and M.H. Nicknam. 2017. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Modern rheumatology 27: 862–867.CrossRef
16.
go back to reference Zeng, L., M.J. Lindstrom, and J.A. Smith. 2011. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis & Rheumatism 63: 3807–3817.CrossRef Zeng, L., M.J. Lindstrom, and J.A. Smith. 2011. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis & Rheumatism 63: 3807–3817.CrossRef
17.
go back to reference Svensson, J., M.C. Jenmalm, A. Matussek, R. Geffers, G. Berg, and J. Ernerudh. 2011. Macrophages at the fetal–maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. The Journal of Immunology 187: 3671–3682.CrossRef Svensson, J., M.C. Jenmalm, A. Matussek, R. Geffers, G. Berg, and J. Ernerudh. 2011. Macrophages at the fetal–maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. The Journal of Immunology 187: 3671–3682.CrossRef
18.
go back to reference Brown, M.B., M. von Chamier, A.B. Allam, and L. Reyes. 2014. M1/M2 macrophage polarity in normal and complicated pregnancy. Frontiers in immunology 5: 606.PubMedPubMedCentral Brown, M.B., M. von Chamier, A.B. Allam, and L. Reyes. 2014. M1/M2 macrophage polarity in normal and complicated pregnancy. Frontiers in immunology 5: 606.PubMedPubMedCentral
19.
go back to reference Schmittgen, T.D., and K.J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101–1108.CrossRef Schmittgen, T.D., and K.J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101–1108.CrossRef
20.
go back to reference Ciccia, F., M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, and A. Craxi. 2009. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60: 955–965.CrossRef Ciccia, F., M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, and A. Craxi. 2009. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60: 955–965.CrossRef
21.
go back to reference Mei, Y., F. Pan, J. Gao, R. Ge, Z. Duan, Z. Zeng, F. Liao, G. Xia, S. Wang, and S. Xu. 2011. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clinical rheumatology 30: 269–273.CrossRef Mei, Y., F. Pan, J. Gao, R. Ge, Z. Duan, Z. Zeng, F. Liao, G. Xia, S. Wang, and S. Xu. 2011. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clinical rheumatology 30: 269–273.CrossRef
22.
go back to reference Appel, H., R. Maier, J. Bleil, A. Hempfing, C. Loddenkemper, U. Schlichting, U. Syrbe, and J. Sieper. 2013. In situ analysis of interleukin–23–and interleukin-12–positive cells in the spine of patients with ankylosing spondylitis. Arthritis & Rheumatism 65: 1522–1529.CrossRef Appel, H., R. Maier, J. Bleil, A. Hempfing, C. Loddenkemper, U. Schlichting, U. Syrbe, and J. Sieper. 2013. In situ analysis of interleukin–23–and interleukin-12–positive cells in the spine of patients with ankylosing spondylitis. Arthritis & Rheumatism 65: 1522–1529.CrossRef
23.
go back to reference DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA–B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA–B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef
24.
go back to reference Cauli, A., G. Dessole, M. Fiorillo, A. Vacca, A. Mameli, P. Bitti, G. Passiu, R. Sorrentino, and A. Mathieu. 2002. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: A possible further susceptibility factor for the development of disease. Rheumatology 41: 1375–1379.CrossRef Cauli, A., G. Dessole, M. Fiorillo, A. Vacca, A. Mameli, P. Bitti, G. Passiu, R. Sorrentino, and A. Mathieu. 2002. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: A possible further susceptibility factor for the development of disease. Rheumatology 41: 1375–1379.CrossRef
25.
go back to reference Liu, S.-Q., H.-C. Yu, Y.-Z. Gong, and N.-S. Lai. 2006. Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis–correlation with clinical activity. The Journal of rheumatology 33: 1128–1132.PubMed Liu, S.-Q., H.-C. Yu, Y.-Z. Gong, and N.-S. Lai. 2006. Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis–correlation with clinical activity. The Journal of rheumatology 33: 1128–1132.PubMed
26.
go back to reference Colbert, R.A., T.M. Tran, and G. Layh-Schmitt. 2014. HLA-B27 misfolding and ankylosing spondylitis. Molecular Immunology 57: 44–51.CrossRef Colbert, R.A., T.M. Tran, and G. Layh-Schmitt. 2014. HLA-B27 misfolding and ankylosing spondylitis. Molecular Immunology 57: 44–51.CrossRef
27.
go back to reference Feng, Y., J. Ding, C.M. Fan, and P. Zhu. 2012. Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. The Journal of rheumatology 39: 574–582.CrossRef Feng, Y., J. Ding, C.M. Fan, and P. Zhu. 2012. Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. The Journal of rheumatology 39: 574–582.CrossRef
28.
go back to reference Gu, J., M. Rihl, E. Märker-Hermann, D. Baeten, J.G. Kuipers, Y.W. Song, W.P. Maksymowych, R. Burgos-Vargas, E.M. Veys, and F. De Keyser. 2002. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. The Journal of Rheumatology 29: 2159–2164.PubMed Gu, J., M. Rihl, E. Märker-Hermann, D. Baeten, J.G. Kuipers, Y.W. Song, W.P. Maksymowych, R. Burgos-Vargas, E.M. Veys, and F. De Keyser. 2002. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. The Journal of Rheumatology 29: 2159–2164.PubMed
29.
go back to reference Ciccia, F., A. Accardo-Palumbo, A. Rizzo, G. Guggino, S. Raimondo, A. Giardina, A. Cannizzaro, R.A. Colbert, R. Alessandro, and G. Triolo. 2014. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the rheumatic diseases 73: 1566–1574.CrossRef Ciccia, F., A. Accardo-Palumbo, A. Rizzo, G. Guggino, S. Raimondo, A. Giardina, A. Cannizzaro, R.A. Colbert, R. Alessandro, and G. Triolo. 2014. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the rheumatic diseases 73: 1566–1574.CrossRef
30.
go back to reference DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef
31.
go back to reference Rahman, P., R.D. Inman, D.D. Gladman, J.P. Reeve, L. Peddle, and W.P. Maksymowych. 2008. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis & Rheumatism 58: 1020–1025.CrossRef Rahman, P., R.D. Inman, D.D. Gladman, J.P. Reeve, L. Peddle, and W.P. Maksymowych. 2008. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis & Rheumatism 58: 1020–1025.CrossRef
32.
go back to reference Reveille, J.D., A.-M. Sims, P. Danoy, D.M. Evans, P. Leo, J.J. Pointon, R. Jin, X. Zhou, L.A. Bradbury, and L.H. Appleton. 2010. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature genetics 42: 123.CrossRef Reveille, J.D., A.-M. Sims, P. Danoy, D.M. Evans, P. Leo, J.J. Pointon, R. Jin, X. Zhou, L.A. Bradbury, and L.H. Appleton. 2010. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature genetics 42: 123.CrossRef
33.
go back to reference Goodall, J.C., C. Wu, Y. Zhang, L. McNeill, L. Ellis, V. Saudek, and J.H. Gaston. 2010. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proceedings of the national academy of Sciences 107: 17698–17703.CrossRef Goodall, J.C., C. Wu, Y. Zhang, L. McNeill, L. Ellis, V. Saudek, and J.H. Gaston. 2010. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proceedings of the national academy of Sciences 107: 17698–17703.CrossRef
34.
go back to reference Turner, M.J., D.P. Sowders, M.L. DeLay, R. Mohapatra, S. Bai, J.A. Smith, J.R. Brandewie, J.D. Taurog, and R.A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. The Journal of Immunology 175: 2438–2448.CrossRef Turner, M.J., D.P. Sowders, M.L. DeLay, R. Mohapatra, S. Bai, J.A. Smith, J.R. Brandewie, J.D. Taurog, and R.A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. The Journal of Immunology 175: 2438–2448.CrossRef
35.
go back to reference de Castro, C.P., S.A. Jones, C.N. Cheallaigh, C.A. Hearnden, L. Williams, J. Winter, E.C. Lavelle, K.H. Mills, and J. Harris. 2012. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. The Journal of Immunology 189: 4144–4153.CrossRef de Castro, C.P., S.A. Jones, C.N. Cheallaigh, C.A. Hearnden, L. Williams, J. Winter, E.C. Lavelle, K.H. Mills, and J. Harris. 2012. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. The Journal of Immunology 189: 4144–4153.CrossRef
36.
go back to reference Chicote, J., V.J. Yuste, J. Boix, and J. Ribas. 2020. Cell death triggered by the autophagy inhibitory drug 3-methyladenine in growing conditions proceeds with DNA damage. Frontiers in Pharmacology 11: 580343. Chicote, J., V.J. Yuste, J. Boix, and J. Ribas. 2020. Cell death triggered by the autophagy inhibitory drug 3-methyladenine in growing conditions proceeds with DNA damage. Frontiers in Pharmacology 11: 580343.
37.
go back to reference Siebert, S., N.L. Millar, and I.B. McInnes. 2019. Why did IL-23p19 inhibition fail in AS: A tale of tissues, trials or translation? Annals of the Rheumatic Diseases 78: 1015–1018.CrossRef Siebert, S., N.L. Millar, and I.B. McInnes. 2019. Why did IL-23p19 inhibition fail in AS: A tale of tissues, trials or translation? Annals of the Rheumatic Diseases 78: 1015–1018.CrossRef
38.
go back to reference Baeten, D., M. Østergaard, J.C. Wei, J. Sieper, P. Järvinen, L.S. Tam, C. Salvarani, T.H. Kim, A. Solinger, Y. Datsenko, et al. 2018. Risankizumab, an IL-23 inhibitor for ankylosing spondylitis: Results of a randomised double-blind placebo-controlled proof-of-concept dose-finding phase 2 study. Annals of the Rheumatic Diseases 77: 1295–1302.CrossRef Baeten, D., M. Østergaard, J.C. Wei, J. Sieper, P. Järvinen, L.S. Tam, C. Salvarani, T.H. Kim, A. Solinger, Y. Datsenko, et al. 2018. Risankizumab, an IL-23 inhibitor for ankylosing spondylitis: Results of a randomised double-blind placebo-controlled proof-of-concept dose-finding phase 2 study. Annals of the Rheumatic Diseases 77: 1295–1302.CrossRef
Metadata
Title
Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients
Authors
Alireza Rezaiemanesh
Mahdi Mahmoudi
Ali Akbar Amirzargar
Mahdi Vojdanian
Farhad Babaie
Jila Mahdavi
Misagh Rajabinejad
Ahmad Reza Jamshidi
Mohammad Hossein Nicknam
Publication date
01-04-2022
Publisher
Springer US
Published in
Inflammation / Issue 2/2022
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01575-z

Other articles of this Issue 2/2022

Inflammation 2/2022 Go to the issue